Subjects

Abstract

Resveratrol (3,5,4′-trihydroxystilbene) extends the lifespan of diverse species including Saccharomyces cerevisiae, Caenorhabditis elegans and Drosophila melanogaster. In these organisms, lifespan extension is dependent on Sir2, a conserved deacetylase proposed to underlie the beneficial effects of caloric restriction. Here we show that resveratrol shifts the physiology of middle-aged mice on a high-calorie diet towards that of mice on a standard diet and significantly increases their survival. Resveratrol produces changes associated with longer lifespan, including increased insulin sensitivity, reduced insulin-like growth factor-1 (IGF-I) levels, increased AMP-activated protein kinase (AMPK) and peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) activity, increased mitochondrial number, and improved motor function. Parametric analysis of gene set enrichment revealed that resveratrol opposed the effects of the high-calorie diet in 144 out of 153 significantly altered pathways. These data show that improving general health in mammals using small molecules is an attainable goal, and point to new approaches for treating obesity-related disorders and diseases of ageing.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Projecting the future of U.S. health and longevity. Health Aff. (Millwood) 24, (suppl. 2)W5R86–W5R89 (2005)

  2. 2.

    , & Health ramifications of the obesity epidemic. Surg. Clin. North Am. 85, 681–701 (2005)

  3. 3.

    et al. Development of calorie restriction mimetics as a prolongevity strategy. Ann. NY Acad. Sci. 1019, 412–423 (2004)

  4. 4.

    Toward a unified theory of caloric restriction and longevity regulation. Mech. Ageing Dev. 126, 987–1002 (2005)

  5. 5.

    & Calorie restriction—the SIR2 connection. Cell 120, 473–482 (2005)

  6. 6.

    et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425, 191–196 (2003)

  7. 7.

    et al. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430, 686–689 (2004)

  8. 8.

    , , & A role for SIR-2.1 regulation of ER stress response genes in determining C. elegans life span. Dev. Cell 9, 605–615 (2005)

  9. 9.

    et al. A novel assay for replicative lifespan in Saccharomyces cerevisiae.. FEMS Yeast Res. 5, 169–177 (2004)

  10. 10.

    et al. Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate. Curr. Biol. 16, 296–300 (2006)

  11. 11.

    et al. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ. Nature 429, 771–776 (2004)

  12. 12.

    et al. SIRT1 protects against microglia-dependent amyloid-β toxicity through inhibiting NF-κB signaling. J. Biol. Chem. 280, 40364–40374 (2005)

  13. 13.

    , , , & Control of AIF-mediated cell death by the functional interplay of SIRT1 and PARP-1 in response to DNA damage. Cell Cycle 5, 873–877 (2006)

  14. 14.

    , & Resveratrol mimics ischemic preconditioning in the brain. J. Cereb. Blood Flow Metab. 26, 1141–1147 (2006)

  15. 15.

    , & Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. J. Biol. Chem. 280, 20589–20595 (2005)

  16. 16.

    The Sir2 family of protein deacetylases. Curr. Opin. Chem. Biol. 9, 431–440 (2005)

  17. 17.

    & Dietary restriction in mice beginning at 1 year of age: effect on life-span and spontaneous cancer incidence. Science 215, 1415–1418 (1982)

  18. 18.

    & Treatment of nonalcoholic fatty liver disease. World J. Gastroenterol. 12, 2161–2167 (2006)

  19. 19.

    & Effects of aging and a high fat diet on body weight and glucose tolerance in glucagon-like peptide-1 receptor-/- mice. Endocrinology 139, 3127–3132 (1998)

  20. 20.

    Chronic activation of AMP-activated kinase as a strategy for slowing aging. Med. Hypotheses 63, 334–339 (2004)

  21. 21.

    , , , & The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans.. Genes Dev. 18, 3004–3009 (2004)

  22. 22.

    et al. Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 55, 2180–2191 (2006)

  23. 23.

    et al. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 310, 314–317 (2005)

  24. 24.

    et al. Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency. Proc. Natl Acad. Sci. USA 103, 1768–1773 (2006)

  25. 25.

    et al. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98, 115–124 (1999)

  26. 26.

    et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413, 131–138 (2001)

  27. 27.

    et al. Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1. Nature 434, 113–118 (2005)

  28. 28.

    et al. GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1α. Cell Metab. 3, 429–438 (2006)

  29. 29.

    , , & Analysis of microarray data using Z score transformation. J. Mol. Diagn. 5, 73–81 (2003)

  30. 30.

    & Therapeutic potential of resveratrol: the in vivo evidence. Nature Rev. Drug Discov. 5, 493–506 (2006)

  31. 31.

    & PAGE: parametric analysis of gene set enrichment. BMC Bioinformatics 6, 144 (2005)

  32. 32.

    et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005)

  33. 33.

    , & Mitochondrial electron transport is a key determinant of life span in Caenorhabditis elegans.. Dev. Cell 1, 633–644 (2001)

  34. 34.

    A conserved regulatory mechanism for aging. Cell 105, 165–168 (2001)

  35. 35.

    et al. Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway. Curr. Biol. 14, 885–890 (2004)

  36. 36.

    et al. Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients. Science 310, 1193–1196 (2005)

  37. 37.

    et al. Calorie restriction mimetics: an emerging research field. Aging Cell 5, 97–108 (2006)

  38. 38.

    Does chronic glycolysis accelerate aging? Could this explain how dietary restriction works?. Ann. NY Acad. Sci. 1067, 361–368 (2006)

  39. 39.

    Liver regeneration: from myth to mechanism. Nature Rev. Mol. Cell Biol. 5, 836–847 (2004)

  40. 40.

    & Growth hormone-induced nuclear translocation of Stat-3 decreases with age: modulation by caloric restriction. Am. J. Physiol. 271, E903–E909 (1996)

  41. 41.

    & Caloric restriction reverses the deficits in leptin receptor protein and leptin signaling capacity associated with diet-induced obesity: role of leptin in the regulation of hypothalamic long-form leptin receptor expression. J. Endocrinol. 181, 297–306 (2004)

  42. 42.

    , & Checkpoint proteins control survival of the postmitotic cells in Caenorhabditis elegans.. Science 312, 1381–1385 (2006)

  43. 43.

    et al. Cidea-deficient mice have lean phenotype and are resistant to obesity. Nature Genet. 35, 49–56 (2003)

  44. 44.

    & in Handbook of the Biology of Aging (eds Masoro, E. J. & Austad, S. N.) 63–104 (Elsevier, Boston, 2006)

Download references

Acknowledgements

We thank H. Rasnow for his donation towards purchasing the mice; V. Massari for help with electron microscopy; W. Matson for HPLC assays of resveratrol; M. Chachich and M. Tatar for help with statistical analysis; W. Wood for microarray assistance; D. Phillips for animal care; J. Egan’s group for insulin measurements; the Sinclair laboratory, N. Wolf, P. Elliott, C. Westphal, R. Weindruch, P. Lambert, J. Milne and M. Milburn for advice on experimental design; and S. Luikenhuis and M. Dipp for critical reading of the manuscript. D.A.S. was supported by The Ellison Medical Research Foundation, J.A.B. by The American Heart Foundation, H.J. and D.LeC. by an Australian NHMRC project grant and an NHMRC post-graduate scholarship, and C.L. and P.P. by the American Diabetes Association and NIH. This research was supported (in part) by the Intramural Research Program of the NIH, NIA, a Spanish MCyT grant to P.N., NIH grants to D.A.S., and by the support of P. F. Glenn and The Paul F. Glenn Laboratories for the Biological Mechanisms of Aging.

Author Contributions All experiments were designed and carried out by J.A.B., K.J.P., R.deC. and D.A.S. with the exceptions noted below. D.K.I. assisted with the design and interpretation of experiments. N.L.P., A.K., J.S.A., K.L. and P.J.P. assisted with the handling of animals and behavioural studies. Electron microscopy was performed by H.A.J. and D.LeC. Computational methods for analysis of microarray data were developed and applied by V.V.P. and K.G.B. Analysis of PGC-1α acetylation was performed by C.L. and P.P. Pathological assessments were made by S.P. (livers), M.W. and E.G.L. (hearts and aortas). In vitro AMPK reactions were performed by D.G. and R.J.S. Citrate synthase activity was measured by O.B. Cell-based mitochondrial assays were performed by G.L.L. and P.N. MRI images were obtained by S.R., K.W.F. and R.G.S.

Author information

Author notes

    • Joseph A. Baur
    •  & Kevin J. Pearson

    These authors contributed equally to this work.

Affiliations

  1. Department of Pathology, Paul F. Glenn Laboratories for the Biological Mechanisms of Aging, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, Massachusetts 02115, USA

    • Joseph A. Baur
    •  & David A. Sinclair
  2. Laboratory of Experimental Gerontology,

    • Kevin J. Pearson
    • , Nathan L. Price
    • , Avash Kalra
    • , Joanne S. Allard
    • , Kaitlyn Lewis
    • , Paul J. Pistell
    • , Donald K. Ingram
    •  & Rafael de Cabo
  3. Gene Expression and Genomics Unit,

    • Vinayakumar V. Prabhu
    •  & Kevin G. Becker
  4. Research Resources Branch,

    • Suresh Poosala
  5. Laboratory of Cardiovascular Science, and

    • Mingyi Wang
    •  & Edward G. Lakatta
  6. Laboratory of Clinical Investigation, Research Resources Branch of the Gerontology Research Center, National Institute on Aging, National Institutes of Health, 5600 Nathan Shock Drive, Baltimore, Maryland 21224, USA

    • Sharan Ramaswamy
    • , Kenneth W. Fishbein
    •  & Richard G. Spencer
  7. Centre for Education and Research on Ageing, and the ANZAC Research Institute University of Sydney, Concord, New South Wales 2139, Australia

    • Hamish A. Jamieson
    •  & David Le Couteur
  8. Department of Cell Biology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA

    • Carles Lerin
    •  & Pere Puigserver
  9. Centro Andaluz de Biologia del Desarrollo, Universidad Pablo de Olavide-CSIC, 41013 Sevilla, Spain

    • Guillermo Lopez-Lluch
    •  & Placido Navas
  10. Sirtris Pharmaceuticals, Inc., 790 Memorial Drive, Cambridge, Massachusetts 02139, USA

    • Olivier Boss
  11. Molecular and Cell Biology Laboratory, The Salk Institute, 10010 N Torrey Pines Road, La Jolla, California 92037, USA

    • Dana Gwinn
    •  & Reuben J. Shaw
  12. Nutritional Neuroscience and Aging Laboratory, Pennington Biomedical Research Center, Louisiana State University System, 6400 Perkins Road, Baton Rouge, Louisiana 70808, USA

    • Donald K. Ingram

Authors

  1. Search for Joseph A. Baur in:

  2. Search for Kevin J. Pearson in:

  3. Search for Nathan L. Price in:

  4. Search for Hamish A. Jamieson in:

  5. Search for Carles Lerin in:

  6. Search for Avash Kalra in:

  7. Search for Vinayakumar V. Prabhu in:

  8. Search for Joanne S. Allard in:

  9. Search for Guillermo Lopez-Lluch in:

  10. Search for Kaitlyn Lewis in:

  11. Search for Paul J. Pistell in:

  12. Search for Suresh Poosala in:

  13. Search for Kevin G. Becker in:

  14. Search for Olivier Boss in:

  15. Search for Dana Gwinn in:

  16. Search for Mingyi Wang in:

  17. Search for Sharan Ramaswamy in:

  18. Search for Kenneth W. Fishbein in:

  19. Search for Richard G. Spencer in:

  20. Search for Edward G. Lakatta in:

  21. Search for David Le Couteur in:

  22. Search for Reuben J. Shaw in:

  23. Search for Placido Navas in:

  24. Search for Pere Puigserver in:

  25. Search for Donald K. Ingram in:

  26. Search for Rafael de Cabo in:

  27. Search for David A. Sinclair in:

Competing interests

D.S. declares that he is a co-founder of Sirtris Pharmaceuticals, a company whose goal is to develop drugs to treat age-related diseases. J.B. and D.S. declare that they are inventors on patents licensed to Sirtris Pharmaceuticals. P.P. declares that he is a member of the scientific advisory board for Sirtris Pharmaceuticals.

Corresponding authors

Correspondence to Rafael de Cabo or David A. Sinclair.

Supplementary information

Word documents

  1. 1.

    Supplementary Notes

    This file contains the Supplementary Methods and additional references. This file was updated on 2 November 2006.

PDF files

  1. 1.

    Supplementary Figures

    This file contains Supplementary Figures 1–7. This file was updated on 2 November 2006.

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/nature05354

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.